BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17185517)

  • 1. FAK signaling in neoplastic disorders: a linkage between inflammation and cancer.
    Mon NN; Ito S; Senga T; Hamaguchi M
    Ann N Y Acad Sci; 2006 Nov; 1086():199-212. PubMed ID: 17185517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and tumor progression: a lesson from TNF-alpha-dependent FAK signaling in cholangiocarcinoma.
    Mon NN; Kokuryo T; Hamaguchi M
    Methods Mol Biol; 2009; 512():279-93. PubMed ID: 19347283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1.
    Mon NN; Hasegawa H; Thant AA; Huang P; Tanimura Y; Senga T; Hamaguchi M
    Cancer Res; 2006 Jul; 66(13):6778-84. PubMed ID: 16818654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction by focal adhesion kinase in cancer.
    Zhao J; Guan JL
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation.
    Cox BD; Natarajan M; Stettner MR; Gladson CL
    J Cell Biochem; 2006 Sep; 99(1):35-52. PubMed ID: 16823799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase promotes the aggressive melanoma phenotype.
    Hess AR; Postovit LM; Margaryan NV; Seftor EA; Schneider GB; Seftor RE; Nickoloff BJ; Hendrix MJ
    Cancer Res; 2005 Nov; 65(21):9851-60. PubMed ID: 16267008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
    Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
    Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAK expression regulation and therapeutic potential.
    Li S; Hua ZC
    Adv Cancer Res; 2008; 101():45-61. PubMed ID: 19055942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
    Schwock J; Dhani N; Hedley DW
    Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
    Joshi B; Strugnell SS; Goetz JG; Kojic LD; Cox ME; Griffith OL; Chan SK; Jones SJ; Leung SP; Masoudi H; Leung S; Wiseman SM; Nabi IR
    Cancer Res; 2008 Oct; 68(20):8210-20. PubMed ID: 18922892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-regulated FAK-Src signaling in normal and cancer cells.
    Mitra SK; Schlaepfer DD
    Curr Opin Cell Biol; 2006 Oct; 18(5):516-23. PubMed ID: 16919435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ; van de Water B
    Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor 1 protein and focal adhesion kinase mediate keratinocyte growth factor signaling in breast cancer cells.
    Zang XP; Pento JT; Tari AM
    Anticancer Res; 2008; 28(1A):133-7. PubMed ID: 18383836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells.
    Knoepp SM; Chahal MS; Xie Y; Zhang Z; Brauner DJ; Hallman MA; Robinson SA; Han S; Imai M; Tomlinson S; Meier KE
    Mol Pharmacol; 2008 Sep; 74(3):574-84. PubMed ID: 18523140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
    Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
    Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
    Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
    Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.
    Chen SY; Chen HC
    Mol Cell Biol; 2006 Jul; 26(13):5155-67. PubMed ID: 16782899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell.
    Ding J; Li D; Wang X; Wang C; Wu T
    Hepatogastroenterology; 2008; 55(88):2072-6. PubMed ID: 19260479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.